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Introduction
Systemic onset Juvenile Idiopathic Arthritis (SoJIA) is a
subset of juvenile idiopathic arthritis (JIA) that describes
patients with intermittent fever, arthritis and skin rash
with complex genetic trait in children less than 16 years
old. The etiology of disease has not yet been identified;
but because of high level of IL-1b in the blood of
patients; and relation between its complications, and clin-
ical signs of disease; the only theory is mutation in factors
which are involved in the control of production and
secretion of this proinflammatory cytokine, like IL-1Ra,
IL-1 type II decoy receptor proteins and soluble IL-1R
accessory protein (IRAP).
Objectives
The aim of this study was to identify the association
between MEFV mutations in exons 2 and 10, and SoJIA
disease in 30 Iranian patients.
Methods
Thirty Iranian children with SoJIA disease and 30 healthy
control, were screened for MEFV mutations in exons 2
and 10 by sequencing. All patients were diagnosed
according to the classification criteria of EULAR for
SoJIA. The control group consisted of 30 healthy indivi-
duals (15 female and 15 male) who did not have any his-
tory of immune system disorders and other diseases with
known genetic or hereditary predisposition.
Results
Statistical analysis showed that the MEFV mutations in
the patients and control groups were significantly differ-
ent (p<0.01). The mutations were detected in 17 of 30
patients (56.6%). The respective figure for the control
subjects was 1 of 30 (3.3%). Leading mutation was
R202Q mutation which detected in 13 patients ( 6 homo-
zygote and 7 heterozygote). Following eight patients had
M694V mutation ( 2 homozygote and 6 heterozygote).
Three patients had E148Q mutation in heterozygote
form.
Conclusion
MEFV mutations may be an important cause of high
level of IL-1b in SoJIA patients. It shows that SoJIA is
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